Cargando…
Interleukin-6 Blocking Therapy for COVID-19: From Immune Pathogenesis to Clinical Outcomes
As a newly emerged infectious disease, the coronavirus disease 2019 (COVID-19) has caused millions of deaths, resulting in a global health challenge. Currently, several vaccines have been approved with significant benefits against disease transmission. However, effective therapies are still needed f...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sciendo
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242140/ https://www.ncbi.nlm.nih.gov/pubmed/35772080 http://dx.doi.org/10.2478/rir-2022-0002 |